Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Arizton forecasts that the Europe laboratory information systems market will reach USD 689.05 million by 2031, driven by AI adoption and digital modernization in laboratory operations.
Haier Biomedical reported 2025 annual revenue of 2.33 billion yuan, with overseas operations contributing a record 36 percent of total revenue. The company highlighted growth in AI applications, new product certifications, and expanded global presence.
Hangzhou-based Diagens reported RMB 164 million in annual revenue for its first year since listing, a 133.7% increase, with licensing from its iMedImage foundation model emerging as the main growth driver.
Caris Life Sciences has published a peer-reviewed study validating its AI-based predictive signature for temozolomide benefit in glioblastoma patients, showing strong concordance with traditional MGMT methylation testing.
Valeris and Fuze Health have agreed to collaborate on integrating digital pharmacy capabilities with patient access and support services. The partnership aims to accelerate therapy initiation and improve coordination across the patient journey.
Zingage has integrated its AI agents with HHAeXchange’s Partner Connect program, giving over 32,000 home care providers access to automation tools for scheduling, phone operations, and compliance management.
SnapCare and connectRN have merged to address healthcare staffing challenges, combining their platforms and clinician networks. The new company also secured Series A funding led by Suvretta Capital to support product innovation and growth.
RIVANNA reported that its Accuro XV ultrasound system produced diagnostic-quality images of extremity injuries when used by non-physicians after brief training, according to a published study.
Complete Genomics announced that AI trained variant calling models reduced genome analysis errors by up to 73 percent compared to standard methods on its DNBSEQ sequencing platform.
DeepLook Medical has won top honors at the 2026 Venture Madness competition for its AI imaging technology that enhances early cancer detection. The company, supported by Xcellerant Ventures, has expanded its operations in Arizona and will conduct upcoming clinical trials with Banner MD Anderson.
Paradigm Health has launched a collaboration with the FDA to develop a model for real time regulatory review of clinical trial data. The project involves trials sponsored by Amgen and AstraZeneca and aims to automate data collection and reporting to speed up reviews.
ACROBiosystems presented its AI-based protein engineering platforms at the AACR Annual Meeting 2026, introducing its Acro-AIx system and related models for protein design and optimization.
Prezent has introduced Prezent Vivo, a new platform combining AI and human expertise to support communication across the full product lifecycle in life sciences. The company also appointed Francine Carrick as President of Prezent Vivo.
Onymos and Mayo Clinic will collaborate to integrate the DocKnow platform into Mayo Clinic’s digital systems, aiming to improve accuracy and efficiency in clinical data management.
Verana Health has launched Agent Claire, an AI tool that helps clinicians streamline data submissions for the Merit-based Incentive Payment System (MIPS). The agent is available through the American Academy of Ophthalmology’s IRIS Registry Quality Measures Dashboard.
IMO Health has announced that developers can now directly access its Clinical Knowledge Graph through GraphQL and MCP interfaces. The system provides a continuously updated clinical context used by most U.S. clinicians, designed to improve the accuracy and explainability of healthcare AI applications.
Maria Ansari, MD, and Ramin Davidoff, MD, co-CEOs of The Permanente Federation, were named to Becker's 2026 Great Leaders in Healthcare list for their work advancing AI tools, supporting clinician wellness, and improving patient outcomes.
Fathom Therapeutics, formerly Atommap Corp., has secured $47 million in an oversubscribed Series A round led by Sutter Hill Ventures. The company uses quantum chemistry and AI through its Microcosmos platform to design small molecule drugs and will use the funds to expand lab and discovery programs.
SquareMind has raised $18 million to expand its AI and robotics platform for dermatology, with plans to launch its Swan robotic skin imaging system in the United States and Europe.
Nomad Health announced its transition from a healthcare staffing agency to a software platform company, offering its AI operating system to staffing firms. The company also appointed Tommy Hickey, formerly of Epic Systems, as CEO.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
